WASHINGTON D.C. — In a stunning development that has pharmaceutical companies scrambling to update their marketing materials, the popular weight-loss drug Ozempic, and its GLP-1 class counterparts, are now believed to offer significant relief from the pervasive, low-level hum of existential dread plaguing contemporary society. The findings, presented at a hastily convened and suspiciously well-catered medical conference, indicate the medications could be a 'one-stop shop' for the modern human condition.

“We initially observed patients reporting less desire for late-night online shopping sprees and a marked decrease in staring blankly at the ceiling at 3 AM,” explained Dr. Anya Sharma, lead researcher for the 'Why Are We Even Here?' study. “Further analysis revealed a significant reduction in the feeling that one's life is merely a series of increasingly disappointing events leading to an inevitable, meaningless end. It’s truly groundbreaking.”

Industry experts are already predicting a surge in prescriptions, with some speculating that the drugs could eventually replace therapy, self-help books, and the entire wellness industry. “Why meditate for years when you can just inject your way to blissful ignorance?” quipped pharmaceutical analyst Chad Broxton. “The market for 'not feeling utterly overwhelmed by everything' is, frankly, enormous.”

Regulators, however, are urging caution, reminding the public that the drugs are still primarily for weight management and heart health, not for coping with the slow, agonizing realization that you’re just a tiny speck in an indifferent universe. But honestly, who's listening?